You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 18, November 12, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Neurology
 •Cardiovascular Interventions, Other
 •Cerebrovascular Disease
 •Cardiovascular System, Other
 •Stroke
 •Cardiovascular System
 •Surgery
 •Surgical Interventions
 •Vascular Surgery
 •Drug Therapy
 •Drug Therapy, Other
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Carotid Endarterectomy and Statin Therapy in the Management of Patients With Carotid Artery Disease—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Management of patients with carotid artery disease is complex. There was insufficient space in the Clinical Crossroads article to discuss the timing of surgery in patients with symptomatic severe carotid artery disease or the intricacies of statin dosage.

I concur with Dr Kapoor that stable patients with surgical internal carotid artery lesions should undergo surgery at the earliest possible time. In unstable patients who have active brain ischemia who are on maximal medical treatment, the nonoperative morbidity and mortality rates are quite high, so surgery (despite the high morbidity) is often more effective than watchful waiting. As Dr Mascitelli and colleagues indicate, physicians should carefully weigh the risks vs benefits in deciding on the type and dosage of a statin in older patients with multiple medical conditions.

Financial Disclosures: Dr Caplan reported that he has been an ad hoc consultant or advisory board member for Bayer, Bristol-Myers Squibb–Sanofi . . . [Full Text of this Article]

Louis R. Caplan, MD
lcaplan@bidmc.harvard.edu
Division of Cerebrovascular/Stroke
Beth Israel Deaconess Medical Center
Boston, Massachusetts



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Carotid Endarterectomy as the Criterion Standard in High-Risk Elderly Patients
Ahmed Suliman, Joshua Greenberg, Ankur Chandra, Samuel Barillas, Pooya Iranpour, and Niren Angle
Arch Surg. 2008;143(8):736-742.
ABSTRACT | FULL TEXT  

A 70-Year-Old Man With a Transient Ischemic Attack: Review of Internal Carotid Artery Stenosis
Louis R. Caplan
JAMA. 2008;300(1):81-90.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Carotid Endarterectomy and Statin Therapy in the Management of Patients With Carotid Artery Disease
John R. Kapoor
JAMA. 2008;300(18):2117-2118.
EXTRACT | FULL TEXT  

Carotid Endarterectomy and Statin Therapy in the Management of Patients With Carotid Artery Disease
Luca Mascitelli, Francesca Pezzetta, and Mark R. Goldstein
JAMA. 2008;300(18):2118.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.